[go: up one dir, main page]

FR2736832B1 - Agent potentialisateur de l'interferon-gamma - Google Patents

Agent potentialisateur de l'interferon-gamma

Info

Publication number
FR2736832B1
FR2736832B1 FR9508723A FR9508723A FR2736832B1 FR 2736832 B1 FR2736832 B1 FR 2736832B1 FR 9508723 A FR9508723 A FR 9508723A FR 9508723 A FR9508723 A FR 9508723A FR 2736832 B1 FR2736832 B1 FR 2736832B1
Authority
FR
France
Prior art keywords
potentializing
interferon
gamma
agent
potentializing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9508723A
Other languages
English (en)
Other versions
FR2736832A1 (fr
Inventor
Jacob Hugues Lortat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to FR9508723A priority Critical patent/FR2736832B1/fr
Priority to PCT/FR1996/001141 priority patent/WO1997003700A2/fr
Publication of FR2736832A1 publication Critical patent/FR2736832A1/fr
Application granted granted Critical
Publication of FR2736832B1 publication Critical patent/FR2736832B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR9508723A 1995-07-19 1995-07-19 Agent potentialisateur de l'interferon-gamma Expired - Fee Related FR2736832B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9508723A FR2736832B1 (fr) 1995-07-19 1995-07-19 Agent potentialisateur de l'interferon-gamma
PCT/FR1996/001141 WO1997003700A2 (fr) 1995-07-19 1996-07-19 Agent modulateur de l'activite de l'interferon-gamma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9508723A FR2736832B1 (fr) 1995-07-19 1995-07-19 Agent potentialisateur de l'interferon-gamma

Publications (2)

Publication Number Publication Date
FR2736832A1 FR2736832A1 (fr) 1997-01-24
FR2736832B1 true FR2736832B1 (fr) 1997-09-19

Family

ID=9481130

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9508723A Expired - Fee Related FR2736832B1 (fr) 1995-07-19 1995-07-19 Agent potentialisateur de l'interferon-gamma

Country Status (2)

Country Link
FR (1) FR2736832B1 (fr)
WO (1) WO1997003700A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2841250B1 (fr) * 2002-06-19 2004-07-23 Commissariat Energie Atomique Composes se liant a l'interferon-gamma, leur procede de preparation, et medicaments les contenant

Also Published As

Publication number Publication date
WO1997003700A3 (fr) 1997-03-20
FR2736832A1 (fr) 1997-01-24
WO1997003700A2 (fr) 1997-02-06

Similar Documents

Publication Publication Date Title
DE59605821D1 (de) l/4-SCALLABSORBER
DE69621528D1 (de) Anti-inflamatorische agenzien
NO981133D0 (no) Ikke-reseptormedierte kontrastmidler
FR2735198B1 (fr) Piece d'accastillage de type manille-cosse
PT828506E (pt) Agentes endoparasiticidas
ID17440A (id) Turunan-turunan peptida
ID19801A (id) Turunan-turunan 5'-deoksi-sitidina
ID16037A (id) Turunan-turunan peptida
NO960353L (no) 4-aminobenzoylguanidinderivater
DE69622664D1 (de) Thixogiessen
BR9709521A (pt) "3-Cianoaril-pirazóis"
NO960392L (no) 4-merkaptobenzoylguanidinderivater
EP0749778A3 (fr) Agent d'absorption
FR2736832B1 (fr) Agent potentialisateur de l'interferon-gamma
FR2735986B3 (fr) Prolongateur d'haltere
KR960003693U (ko) 남성용 팬티
UA10890A (uk) Мікроіh'єктор
KR970000413U (ko) 남성용 신체단련기
KR960001317U (ko) 카스테레오의 고정구조
KR970019493U (ko) 브이씨알의 케이스
KR950025292U (ko) 자동차의 마후라
UA680S (uk) Судно-службово-роз'їздне
BR7401400U (pt) "Cool-fast
ITCT940031A0 (it) "sbufi"
UA27881C2 (uk) Мийно-дезінфекційний засіб "збруч-2"

Legal Events

Date Code Title Description
TQ Partial transmission of property
TP Transmission of property
ST Notification of lapse